NASDAQ:LHCG - LHC Group Stock Price, News & Analysis

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

LHC Group, Inc. (NASDAQ:LHCG) issued its earnings results on Wednesday, August, 7th. The health services provider reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.01 by $0.06. The health services provider had revenue of $517.84 million for the quarter, compared to analysts' expectations of $524.24 million. LHC Group had a net margin of 4.20% and a return on equity of 8.83%. The business's revenue was up 3.2% on a year-over-year basis. During the same quarter last year, the business earned $0.84 earnings per share. View LHC Group's Earnings History.

LHC Group is scheduled to release their next quarterly earnings announcement on Wednesday, October 30th 2019. View Earnings Estimates for LHC Group.

LHC Group updated its FY19 earnings guidance on Wednesday, August, 7th. The company provided earnings per share guidance of $4.25 to $4.35 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.31. The company issued revenue guidance of $2.09-2.14 billion, compared to the consensus revenue estimate of $2.11 billion.

11 Wall Street analysts have issued 1-year price objectives for LHC Group's stock. Their predictions range from $114.00 to $146.00. On average, they anticipate LHC Group's share price to reach $126.40 in the next year. This suggests a possible upside of 6.2% from the stock's current price. View Analyst Price Targets for LHC Group.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for LHC Group.

News articles about LHCG stock have trended positive this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. LHC Group earned a media sentiment score of 2.5 on InfoTrie's scale. They also assigned media headlines about the health services provider a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the company's share price in the immediate future. View News Stories for LHC Group.

Some companies that are related to LHC Group include Chemed (CHE), Amedisys (AMED), Addus Homecare (ADUS), Civitas Solutions (CIVI), BioScrip (BIOS) and New York Health Care (BBAL).

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Home Depot (HD), Cisco Systems (CSCO), Verizon Communications (VZ), Honeywell International (HON), Johnson & Johnson (JNJ), Alibaba Group (BABA), Thermo Fisher Scientific (TMO), Visa (V), Chevron (CVX) and UnitedHealth Group (UNH).

LHC Group's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (15.75%), BlackRock Inc. (15.74%), Vanguard Group Inc. (9.88%), Invesco Ltd. (3.16%), Bank of New York Mellon Corp (1.79%) and TimesSquare Capital Management LLC (1.77%). Company insiders that own LHC Group stock include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View Institutional Ownership Trends for LHC Group.

LHCG stock was sold by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Chartwell Investment Partners LLC, Rothschild & Co. Asset Management US Inc., Penn Capital Management Co. Inc., Bank of New York Mellon Corp, Royal Bank of Canada, Moody Aldrich Partners LLC and Russell Investments Group Ltd.. Company insiders that have sold LHC Group company stock in the last year include Donald Dwayne Stelly, Jeff Reibel, John L Indest, Joshua L Proffitt, Keith G Myers, Ronald T Nixon and Tyree G Wilburn. View Insider Buying and Selling for LHC Group.

LHCG stock was bought by a variety of institutional investors in the last quarter, including Invesco Ltd., BlackRock Inc., BlackRock Inc., Nuveen Asset Management LLC, Janus Henderson Group PLC, Janus Henderson Group PLC, Morgan Stanley and Victory Capital Management Inc.. View Insider Buying and Selling for LHC Group.

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of LHCG stock can currently be purchased for approximately $119.05.

LHC Group has a market capitalization of $3.75 billion and generates $1.81 billion in revenue each year. The health services provider earns $63.57 million in net income (profit) each year or $3.55 on an earnings per share basis. LHC Group employs 30,985 workers across the globe.View Additional Information About LHC Group.

The official website for LHC Group is http://www.lhcgroup.com/.

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]